Raymond James & Associates’s Viridian Therapeutics VRDN Stock Holding History

Raymond James & Associates’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$509K	Buy
2024 Q2	$149K	Sell
2024 Q1	$202K	Buy
2023 Q4	$223K	Sell
2023 Q3	$233K	Buy
2023 Q2	$211K	Sell
2023 Q1	$232K	Buy
2018 Q4	–	Sell
2018 Q3	$125K	Buy
2018 Q2	$135K	Buy